相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。A White Paper-Consensus and Recommendations of a Global Harmonization Team on Assessing the Impact of Immunogenicity on Pharmacokinetic Measurements
J. M. Sailstad et al.
AAPS JOURNAL (2014)
Assessment and Reporting of the Clinical Immunogenicity of Therapeutic Proteins and Peptides-Harmonized Terminology and Tactical Recommendations
G. Shankar et al.
AAPS JOURNAL (2014)
Innovative Use of LC-MS/MS for Simultaneous Quantitation of Neutralizing Antibody, Residual Drug, and Human Immunoglobulin G in Immunogenicity Assay Development
Hao Jiang et al.
ANALYTICAL CHEMISTRY (2014)
Targeted Quantitation of Proteins by Mass Spectrometry
Daniel C. Liebler et al.
BIOCHEMISTRY (2013)
Advances in the quantitation of therapeutic insulin analogues by LC-MS/MS
Michael Blackburn
BIOANALYSIS (2013)
General LC-MS/MS Method Approach to Quantify Therapeutic Monoclonal Antibodies Using a Common Whole Antibody Internal Standard with Application to Preclinical Studies
Hongyan Li et al.
ANALYTICAL CHEMISTRY (2012)
A universal surrogate peptide to enable LC-MS/MS bioanalysis of a diversity of human monoclonal antibody and human Fc-fusion protein drug candidates in pre-clinical animal studies
Michael T. Furlong et al.
BIOMEDICAL CHROMATOGRAPHY (2012)
A Survey of Applications of Biological Products for Drug Interference of Immunogenicity Assays
Yow-Ming C. Wang et al.
PHARMACEUTICAL RESEARCH (2012)
Taking immunogenicity assessment of therapeutic proteins to the next level
I. C. Buettel et al.
BIOLOGICALS (2011)
Recommendations for the validation of cell-based assays used for the detection of neutralizing antibody immune responses elicited against biological therapeutics
Shalini Gupta et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2011)
AN OVERVIEW OF MATRIX EFFECTS IN LIQUID CHROMATOGRAPHY-MASS SPECTROMETRY
Helga Trufelli et al.
MASS SPECTROMETRY REVIEWS (2011)
A strategy for liquid chromatography/tandem mass spectrometry based quantitation of pegylated protein drugs in plasma using plasma protein precipitation with water-miscible organic solvents and subsequent trypsin digestion to generate surrogate peptides for detection
Steven T. Wu et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2011)
An immunoaffinity liquid chromatography-tandem mass spectrometry assay for the quantitation of matrix metalloproteinase 9 in mouse serum
Mireia Fernandez Ocana et al.
ANALYTICAL BIOCHEMISTRY (2010)
Mass Spectrometry Based Targeted Protein Quantification: Methods and Applications
Sheng Pan et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Human immunoglobulin allotypes Possible implications for immunogenicity
Roy Jefferis et al.
MABS (2009)
Towards absolute quantification of therapeutic monoclonal antibody in serum by LC-MS/MS using isotope-labeled antibody standard and protein cleavage isotope dilution mass spectrometry
Olivier Heudi et al.
ANALYTICAL CHEMISTRY (2008)
Immunopurification and mass spectrometric quantification of the active form of a chimeric therapeutic antibody in human serum
Mathieu Dubois et al.
ANALYTICAL CHEMISTRY (2008)
Assessing immunogenicity in the presence of excess protein therapeutic using immunoprecipitation and quantitative mass spectrometry
Hendrik Neubert et al.
ANALYTICAL CHEMISTRY (2008)
Quantification of Thyroglobulin, a Low-Abundance Serum Protein, by Immunoaffinity Peptide Enrichment and Tandem Mass Spectrometry
Andrew N. Hoofnagle et al.
CLINICAL CHEMISTRY (2008)
Recommendations on risk-based strategies for detection and characterization of antibodies against biotechnology products
Eugen Koren et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2008)
Recommendations for the validation of immunoassays used for detection of host antibodies against biotechnology products
Gopi Shankar et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2008)
Selected reaction monitoring for quantitative proteomics: a tutorial
Vinzenz Lange et al.
MOLECULAR SYSTEMS BIOLOGY (2008)
Detection of antibodies against therapeutic proteins in the presence of residual therapeutic protein using a solid-phase extraction with acid dissociation (SPEAD) sample treatment prior to ELISA
Holly W. Smith et al.
REGULATORY TOXICOLOGY AND PHARMACOLOGY (2007)
An affinity capture elution (ACE) assay for detection of anti-drug antibody to monoclonal antibody therapeutics in the presence of high levels of drug
James S. Bourdage et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Comparing ELISA and surface plasmon resonance for assessing clinical immunogenicity of panitumumab
James A. Lofgren et al.
JOURNAL OF IMMUNOLOGY (2007)
A risk-based bioanalytical strategy for the assessment of antibody immune responses against biological drugs
Gopi Shankar et al.
NATURE BIOTECHNOLOGY (2007)
Recommendations for the design, optimization, and qualification of cell-based assays used for the detection of neutralizing antibody responses elicited to biological therapeutics
Shalini Gupta et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2007)
Immunogenicity of xenopeptide hormone therapies
Catherine A. Schnabel et al.
PEPTIDES (2006)
From B cell to plasma cell - Regulation of V(D)J recombination and antibody secretion
Lisa Borghesi et al.
IMMUNOLOGIC RESEARCH (2006)
An acid dissociation bridging ELISA for detection of antibodies directed against therapeutic proteins in the presence of antigen
A Patton et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2005)
Rationally engineered therapeutic proteins with reduced immunogenicity
S Tangri et al.
JOURNAL OF IMMUNOLOGY (2005)
Recommendations for the design and optimization of immunoassays used in the detection of host antibodies against biotechnology products
AR Mire-Sluis et al.
JOURNAL OF IMMUNOLOGICAL METHODS (2004)
Bioequivalence and the immunogenicity of biopharmaceuticals
H Schellekens
NATURE REVIEWS DRUG DISCOVERY (2002)
分享论文
